March 18, 2024Enhancing in vitro cardiotoxicity models with human iPSC technologyWith cardiotoxicity continuing to challenge drug discovery and rising rates of cardiac arrhythmias, advanced in vitro cardiac models are gaining…Author:
March 11, 2024Managing quality in iPSC-derived cell manufacturing – a decade-long journeyAt Axol Bioscience, we have over a decade of experience…
March 7, 2024New product launch: axoCellsTM Atrial Cardiomyocyte kit for better arrhythmia and cardiotoxicity modelingAs part of our ongoing efforts to support researchers looking…
March 5, 2024Unlocking iPSC technology for better in vitro Huntington’s Disease modelsAt Axol Bioscience, we’re utilizing over a decade of experience to help…
February 19, 2024Disease focus: building better in vitro ALS models with human iPSC technologyAs part of our 2024 Disease Focus area, we have…
February 15, 2024Functional QC: the next step to unlocking better in vitro models with greater translational powerAt Axol Bioscience, we’ve been using iPSCs in a quality-focused…
February 1, 2024Axol Bioscience and NETRI sign product supply agreementWe’re excited to announce the signing of a product supply…
January 1, 2024Axol, the first choice for iPSCs. 2024 pricing and promotions.2023 has been a big year for iPSC technology. Driven by…
November 21, 2023Axol CEO end-of-year review 2023The time is now: driving the growth of iPSC technology…
November 9, 2023Our pledge to the iPSC marketA pledge and a promotion… Here at Axol Bioscience, we’re…
November 8, 2023Axol Bioscience will be presenting a key new poster written in partnership with Sumitomo Pharma America, Inc. at Neuroscience 2023 Washington D.C.Next week, Washington D.C. plays host to Neuroscience 2023, SfN.…
November 1, 2023Advancing the use of iPSC-derived microglia for drug discoveryAccelerating neuroinflammatory drug discovery with iPSC-derived microglia As rates of…
November 1, 2023Axol Bioscience’s ongoing commitment to support pharmaceutical companies in Japan with iPSC excellenceAxol Bioscienceは世界をリードするiPS細胞の専門知識で日本の創薬研究をサポートします As market leaders in the induced pluripotent stem…